Report Detail
Global and Japan Pet Pharmaceuticals Market Insights, Forecast to 2026
- RnM4182491 |
- 01 September, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Pharma & Healthcare
Pet Pharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pet Pharmaceuticals market is segmented into
Pill
Injection
Spray
Ointment
Others
Segment by Application, the Pet Pharmaceuticals market is segmented into
Treatment
Prevention
Regional and Country-level Analysis
The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck Animal Health
Merial
Elanco
Bayer
Boehringer Ingolheim
Novartis
Virbac Group
Ceva Sante Animale
Vétoquinol S.A.
1 Study Coverage
- 1.1 Pet Pharmaceuticals Product Introduction
- 1.2 Market Segments
- 1.3 Key Pet Pharmaceuticals Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type
- 1.4.2 Pill
- 1.4.3 Injection
- 1.4.4 Spray
- 1.4.5 Ointment
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Pet Pharmaceuticals Market Size Growth Rate by Application
- 1.5.2 Treatment
- 1.5.3 Prevention
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pet Pharmaceuticals Market Size, Estimates and Forecasts
- 2.1.1 Global Pet Pharmaceuticals Revenue 2015-2026
- 2.1.2 Global Pet Pharmaceuticals Sales 2015-2026
- 2.2 Global Pet Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Pet Pharmaceuticals Historical Market Size by Region (2015-2020)
- 2.3.1 Global Pet Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Pet Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Pet Pharmaceuticals Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Pet Pharmaceuticals Sales Forecast by Region (2021-2026)
- 2.4.2 Global Pet Pharmaceuticals Revenue Forecast by Region (2021-2026)
3 Global Pet Pharmaceuticals Competitor Landscape by Players
- 3.1 Global Top Pet Pharmaceuticals Sales by Manufacturers
- 3.1.1 Global Pet Pharmaceuticals Sales by Manufacturers (2015-2020)
- 3.1.2 Global Pet Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Pet Pharmaceuticals Manufacturers by Revenue
- 3.2.1 Global Pet Pharmaceuticals Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2019
- 3.2.5 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Pet Pharmaceuticals Price by Manufacturers
- 3.4 Global Pet Pharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pet Pharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Pet Pharmaceuticals Market Size by Type (2015-2020)
- 4.1.1 Global Pet Pharmaceuticals Sales by Type (2015-2020)
- 4.1.2 Global Pet Pharmaceuticals Revenue by Type (2015-2020)
- 4.1.3 Pet Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pet Pharmaceuticals Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
- 4.2.3 Pet Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pet Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Pet Pharmaceuticals Market Size by Application (2015-2020)
- 5.1.1 Global Pet Pharmaceuticals Sales by Application (2015-2020)
- 5.1.2 Global Pet Pharmaceuticals Revenue by Application (2015-2020)
- 5.1.3 Pet Pharmaceuticals Price by Application (2015-2020)
- 5.2 Pet Pharmaceuticals Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pet Pharmaceuticals Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 6.1.1 Japan Pet Pharmaceuticals Sales YoY Growth 2015-2026
- 6.1.2 Japan Pet Pharmaceuticals Revenue YoY Growth 2015-2026
- 6.1.3 Japan Pet Pharmaceuticals Market Share in Global Market 2015-2026
- 6.2 Japan Pet Pharmaceuticals Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Pet Pharmaceuticals Players by Sales (2015-2020)
- 6.2.2 Japan Top Pet Pharmaceuticals Players by Revenue (2015-2020)
- 6.3 Japan Pet Pharmaceuticals Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Pet Pharmaceuticals Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Pet Pharmaceuticals Price by Type (2015-2020)
- 6.4 Japan Pet Pharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Pet Pharmaceuticals Price Forecast by Type (2021-2026)
- 6.5 Japan Pet Pharmaceuticals Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Pet Pharmaceuticals Price by Application (2015-2020)
- 6.6 Japan Pet Pharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Pet Pharmaceuticals Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 7.2 North America Pet Pharmaceuticals Market Facts & Figures by Country
- 7.2.1 North America Pet Pharmaceuticals Sales by Country (2015-2020)
- 7.2.2 North America Pet Pharmaceuticals Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 8.2 Europe Pet Pharmaceuticals Market Facts & Figures by Country
- 8.2.1 Europe Pet Pharmaceuticals Sales by Country
- 8.2.2 Europe Pet Pharmaceuticals Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Country
- 9.2.1 Asia Pacific Pet Pharmaceuticals Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Pet Pharmaceuticals Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 10.2 Latin America Pet Pharmaceuticals Market Facts & Figures by Country
- 10.2.1 Latin America Pet Pharmaceuticals Sales by Country
- 10.2.2 Latin America Pet Pharmaceuticals Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Pet Pharmaceuticals Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
- 11.2.2 Middle East and Africa Pet Pharmaceuticals Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Zoetis
- 12.1.1 Zoetis Corporation Information
- 12.1.2 Zoetis Description and Business Overview
- 12.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Zoetis Pet Pharmaceuticals Products Offered
- 12.1.5 Zoetis Recent Development
- 12.2 Merck Animal Health
- 12.2.1 Merck Animal Health Corporation Information
- 12.2.2 Merck Animal Health Description and Business Overview
- 12.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
- 12.2.5 Merck Animal Health Recent Development
- 12.3 Merial
- 12.3.1 Merial Corporation Information
- 12.3.2 Merial Description and Business Overview
- 12.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Merial Pet Pharmaceuticals Products Offered
- 12.3.5 Merial Recent Development
- 12.4 Elanco
- 12.4.1 Elanco Corporation Information
- 12.4.2 Elanco Description and Business Overview
- 12.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Elanco Pet Pharmaceuticals Products Offered
- 12.4.5 Elanco Recent Development
- 12.5 Bayer
- 12.5.1 Bayer Corporation Information
- 12.5.2 Bayer Description and Business Overview
- 12.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Bayer Pet Pharmaceuticals Products Offered
- 12.5.5 Bayer Recent Development
- 12.6 Boehringer Ingolheim
- 12.6.1 Boehringer Ingolheim Corporation Information
- 12.6.2 Boehringer Ingolheim Description and Business Overview
- 12.6.3 Boehringer Ingolheim Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
- 12.6.5 Boehringer Ingolheim Recent Development
- 12.7 Novartis
- 12.7.1 Novartis Corporation Information
- 12.7.2 Novartis Description and Business Overview
- 12.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Novartis Pet Pharmaceuticals Products Offered
- 12.7.5 Novartis Recent Development
- 12.8 Virbac Group
- 12.8.1 Virbac Group Corporation Information
- 12.8.2 Virbac Group Description and Business Overview
- 12.8.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Virbac Group Pet Pharmaceuticals Products Offered
- 12.8.5 Virbac Group Recent Development
- 12.9 Ceva Sante Animale
- 12.9.1 Ceva Sante Animale Corporation Information
- 12.9.2 Ceva Sante Animale Description and Business Overview
- 12.9.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
- 12.9.5 Ceva Sante Animale Recent Development
- 12.10 Vétoquinol S.A.
- 12.10.1 Vétoquinol S.A. Corporation Information
- 12.10.2 Vétoquinol S.A. Description and Business Overview
- 12.10.3 Vétoquinol S.A. Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Vétoquinol S.A. Pet Pharmaceuticals Products Offered
- 12.10.5 Vétoquinol S.A. Recent Development
- 12.11 Zoetis
- 12.11.1 Zoetis Corporation Information
- 12.11.2 Zoetis Description and Business Overview
- 12.11.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Zoetis Pet Pharmaceuticals Products Offered
- 12.11.5 Zoetis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pet Pharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pet Pharmaceuticals. Industry analysis & Market Report on Pet Pharmaceuticals is a syndicated market report, published as Global and Japan Pet Pharmaceuticals Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Pet Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
